Revance Therapeutics Free Cash Flow (Quarterly) Analysis

Revance Therapeutics Inc (RVNC)

3.40 +0.11 (+3.34%) USD | NASDAQ | Apr 26, 16:00

3.40 0.00 (0.00%) After-Hours: 20:00

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	-44.51M
September 30, 2023	-55.46M
June 30, 2023	-53.12M
March 31, 2023	-70.37M
December 31, 2022	-31.47M
September 30, 2022	-58.87M
June 30, 2022	-43.69M
March 31, 2022	-62.73M
December 31, 2021	-48.97M
September 30, 2021	-50.67M
June 30, 2021	-53.48M
March 31, 2021	-78.79M
December 31, 2020	-64.52M
September 30, 2020	-56.46M
June 30, 2020	-17.79M
March 31, 2020	-43.95M
December 31, 2019	-33.80M
September 30, 2019	-33.43M
June 30, 2019	-29.66M
March 31, 2019	-12.50M
December 31, 2018	-340.68M
September 30, 2018	-28.44M

Date	Value
June 30, 2018	-37.92M
March 31, 2018	-12.21M
December 31, 2017	-28.88M
September 30, 2017	-21.99M
June 30, 2017	-25.60M
March 31, 2017	-21.49M
December 31, 2016	-13.99M
September 30, 2016	-14.51M
June 30, 2016	-18.43M
March 31, 2016	-16.37M
December 31, 2015	-16.93M
September 30, 2015	-14.26M
June 30, 2015	-12.98M
March 31, 2015	-14.83M
December 31, 2014	-10.65M
September 30, 2014	-14.72M
June 30, 2014	-14.59M
March 31, 2014	-22.09M
December 31, 2013	-17.78M
September 30, 2013	-6.827M
June 30, 2013	-22.72M
March 31, 2013	-6.908M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-78.79M

Minimum

Mar 2021

-17.79M

Maximum

Jun 2020

-49.04M

Average

-50.67M

Median

Sep 2021

Free Cash Flow (Quarterly) Benchmarks